Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial Frias JP, Deenadayalan S, Erichsen L, et al
Community reports suggest subjective changes (energy, recovery) may emerge within 1-2 weeks, with more noticeable effects over 4-6 weeks
3000 L- 50 -
Since GLP-1s act as an appetite suppressant, its important to pay even closer attention to your body
Furthermore, the growth hormone released in response to Ipamorelin also aids in muscle recovery, repair, endurance and overall performance enhancement